Erik Kupperman

Statistics

Publications

Citations

1.5K

H-Index

Active since

1993

Affiliations

Millennium Engineering and Integration (United States)(Current)

University of California San Diego

Takeda (United States)

Alexion Pharmaceuticals (United States)

University of California, San Francisco

Erik Kupperman is an author at Millennium Engineering and Integration (United States) specializing in life sciences, signal transduction, and medicine.

Publications per year

1993–2024

Publications

Evaluation of the Proteasome Inhibitor MLN9708 in Preclinical Models of Human Cancer

Erik Kupperman, Edmund C. Lee, Yueying Cao et al. · Cancer Research · 2010 · 493 citations

Medicine, Oncology, Pharmacology +13

A sphingosine-1-phosphate receptor regulates cell migration during vertebrate heart development

Erik Kupperman, Songzhu An, Steven Waldron et al. · Nature · 2000 · 400 citations

Life Sciences, Cell Biology, Developmental Biology +16

Antitumor Activity of the Investigational Proteasome Inhibitor MLN9708 in Mouse Models of B-cell and Plasma Cell Malignancies

Edmund C. Lee, Michael Fitzgerald, Bret Bannerman et al. · Clinical Cancer Research · 2011 · 106 citations

Medicine, Oncology, Pharmacology +16

TAK-960, a Novel, Orally Available, Selective Inhibitor of Polo-Like Kinase 1, Shows Broad-spectrum Preclinical Antitumor Activity in Multiple Dosing Regimens

Yuichi Hikichi, Kohei Honda, Kouki Hikami et al. · Molecular Cancer Therapeutics · 2011 · 77 citations · Full text

Medicine, Oncology, Pharmacology +11

RalGDS Functions in Ras- and cAMP-mediated Growth Stimulation

Marsha J. Miller, Sally A. Prigent, Erik Kupperman et al. · Journal of Biological Chemistry · 1997 · 74 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +15

1–5 of 14